$300 Savings Ends in:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Agenda for Day 2 – Thursday December 10, 2026 - US/Eastern
As regulatory expectations continue to rise, pharmacies must move beyond minimum compliance requirements and establish quality systems capable of supporting long-term growth.
Discussion Topics
Inspection readiness strategies
CAPA effectiveness
Documentation practices
Quality culture development
Long-term compliance sustainability
- Arpita Sammons - Director, Quality and Regulatory Compliance, Curexa
- Victor Hill - Director of Quality, Vios Compounding
- Jamal Almustapha - Vice President of Quality, Strive Pharmacy
Compliance investments can strengthen long-term viability—but only when aligned with operational realities and business objectives.
Discussion Topics
Financial realities of cGMP, QA and infrastructure investment
Long-term defensibility
Scaling quality systems
Avoiding overbuilding or underbuilding
Balancing compliance and profitability
- David Medina - Assistant Compliance Officer, Americare Pharmaceutical Services
Veterinary compounding remains a growing area of opportunity but presents unique regulatory and operational considerations.
Discussion Topics
Regulatory expectations
Quality considerations
Veterinary prescribing practices
Species-specific challenges
Market opportunities
- Erika Fallon - Pharmacist and Owner, Fallon Wellness Pharmacy
- Vinnie Dam - Founder / Chief Pharmacy Officer, Mixlab
- Lawrence Rossetti - Chief Executive Officer, Drug Crafters Pharmacy
- Norman Petty - General Counsel and EVP, Business Affairs, Noom
- Learn how to navigate critical USP <797> and <800> compliance requirements, including facility design, environmental monitoring, and personnel training
- Discover how to implement robust standard operating procedures, quality assurance protocols, and effective risk assessments
- Master environmental monitoring programs and quality control strategies to ensure patient safety
- Prepare for regulatory inspections with actionable documentation and readiness best practices
- Adapt sterile compounding operations to meet evolving regulatory expectations
- Tyler Chamberlain - Director of Compliance, Strive Compounding Pharmacy
- Jonathan Rekieta - Senior Director, Compounding, ReviveRx
Join peers for facilitated, discussions focused on the strategic, operational, and compliance challenges shaping the future of compounding. Attendees will participate in small-group conversations designed to encourage candid dialogue, practical problem-solving, and peer-to-peer knowledge sharing.
Roundtable Topics
Emerging Business Models: Telehealth, Med Spas, Veterinary, and Other Growth Opportunities
Navigating Inspections, Audits, and State Board Expectations
Quality Systems That Scale: Balancing Compliance, Efficiency, and Growth
Peptides, GLP-1s, and Other High-Interest Compounded Therapies
Supply Chain, Sourcing, and Distribution Challenges Across Compounding
Preparing for What’s Next: Industry Trends, Market Pressures, and Strategic Priorities
- Scott Welch - President, Preston’s Pharmacy